Search research articles
Contact Us
Filters
Showing results (111-120 of 199) with videos related to
Page
of 20
Sort By:
Cytotechnology
|
February 24, 2012
Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cells
C K Chin, P R Schofield, D M Robertson, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 2, 2007
Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection
K Kessenbrock, M J Fritzler, M Groves, et al.
Nano Letters
|
November 23, 2021
Massive and Topological Surface States in Tensile-Strained HgTe
David M Mahler, Valentin L Müller, Cornelius Thienel, et al.
Scientific Reports
|
June 12, 2026
Bioinformatic pipeline to identify potential therapeutic targets with subsequent isolation and characterization of novel human anti- DDR1 antibodies
Divya Agrawal, Stephen M Mahler, Anurag S Rathore, et al.
Rheumatology International
|
January 31, 2025
Barriers and facilitators to treat-to-target in axial spondyloarthritis in clinical practice: a mixed methods study
Marius L Smits, Casper Webers, Mirte van Dooren, et al.
Journal of Community Health
|
January 1, 1989
Ethical issues in primary health care: a survey of practitioners' perceptions
H M Robillard, D M High, J G Sebastian, et al.
Plos One
|
July 7, 2017
Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay
Kebaneilwe Lebani, Martina L Jones, Daniel Watterson, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Adverse events and discomfort in studies on healthy subjects: the volunteer's perspective. A survey conducted by the German Association for Applied Human Pharmacology
R Hermann, D Heger-Mahn, M Mahler, et al.
BMC Cancer
|
December 11, 2020
A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells
Maria E Lund, Christopher B Howard, Kristofer J Thurecht, et al.
International Journal of Rheumatic Diseases
|
December 30, 2016
Biosimilars approved for treatment of inflammatory rheumatological diseases
Stephen M Mahler, Andri Wardiana, Martina L Jones, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 199) with videos related to
Sort By:
Page
of 20
Cytotechnology
|
February 24, 2012
Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cells
C K Chin, P R Schofield, D M Robertson, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 2, 2007
Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection
K Kessenbrock, M J Fritzler, M Groves, et al.
Nano Letters
|
November 23, 2021
Massive and Topological Surface States in Tensile-Strained HgTe
David M Mahler, Valentin L Müller, Cornelius Thienel, et al.
Scientific Reports
|
June 12, 2026
Bioinformatic pipeline to identify potential therapeutic targets with subsequent isolation and characterization of novel human anti- DDR1 antibodies
Divya Agrawal, Stephen M Mahler, Anurag S Rathore, et al.
Rheumatology International
|
January 31, 2025
Barriers and facilitators to treat-to-target in axial spondyloarthritis in clinical practice: a mixed methods study
Marius L Smits, Casper Webers, Mirte van Dooren, et al.
Journal of Community Health
|
January 1, 1989
Ethical issues in primary health care: a survey of practitioners' perceptions
H M Robillard, D M High, J G Sebastian, et al.
Plos One
|
July 7, 2017
Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay
Kebaneilwe Lebani, Martina L Jones, Daniel Watterson, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Adverse events and discomfort in studies on healthy subjects: the volunteer's perspective. A survey conducted by the German Association for Applied Human Pharmacology
R Hermann, D Heger-Mahn, M Mahler, et al.
BMC Cancer
|
December 11, 2020
A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells
Maria E Lund, Christopher B Howard, Kristofer J Thurecht, et al.
International Journal of Rheumatic Diseases
|
December 30, 2016
Biosimilars approved for treatment of inflammatory rheumatological diseases
Stephen M Mahler, Andri Wardiana, Martina L Jones, et al.
Page
of 20